We use cookies for a better user experience. Read our Privacy Policy

I Agree

Topical Pain Management Therapeutics in Sports Medicine Market

Topical Pain Management Therapeutics in Sports Medicine Market (Product - Gels, Cream, Sprays, and Patches (Drug in Adhesive, Matrix, and Reservoirs); Therapeutic Class - Analgesics (Opioids, Non-opioids), Anesthetics, and Skeletal Muscle Relaxants) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global topical pain management therapeutics in sports medicine market for the historical period 2017–2018 and forecast period 2019–2027, rise in demand for cost-effective and instant pain relief therapeutics by national and international sports players, improved distribution of the pain relief therapeutics in developing countries  and introduction of novel pipeline product are projected to drive the global topical pain management therapeutics in sports medicine market during the forecast period
  • According to the report, the global topical pain management therapeutics in sports medicine market was valued at US$ 1.6 Bn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027

To know the scope of our report Get a Sample on Topical Pain Management Therapeutics in Sports Medicine Market

Increase in Incidence of Musculoskeletal Acute Sports Injuries: Key Drivers

  • Growing participation of population in sports activities is leading to increase in number of acute sports injuries, which is expected to drive demand for topical pain management therapeutics in sports medicine market
  • According to the National Health Statistics Reports (NHSR), there were an estimated 10.5 million sports injuries in the U.S. in 2015, of which over 40% (4.2 million) injuries included strains and sprains along with other acute injuries
  • According to the National Health Statistics Reports (NHSR), there were an estimated 10.5 million sports injuries in the U.S. in 2015, of which over 40% (4.2 million) injuries included strains and sprains along with other acute injuries.

Increase in implementation of guidelines promoting topical boost topical pain management therapeutics in sports medicine market growth

  • Various agencies in the U.S. and Europe have laid down guidelines for the treatment of osteoarthritis, which emphasize on the use of topical pain relief products as the first line of treatment
  • These agencies include the American Association of Orthopedic Surgeons (AAOS), the American College of Rheumatology (ACR), the National Institute for Health and Clinical Excellence (NICE, U.K.), the American Pain Society (APS), the European League Against Rheumatism (EULAR), and Osteoarthritis Research Society International (OARSI)
  • The American College of Rheumatology (ACR), in 2012, implemented guidelines, which suggested use of topical capsaicin and topical NSAID with trolamine salicylate for the treatment of osteoarthritis of hand

Get a glimpse of the in-depth analysis through our Report Brochure

Global Topical Pain Management Therapeutics in Sports Medicine Market: Competitive Landscape

  • This report profiles major players in the global topical pain management therapeutics in sports medicine market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global topical pain management therapeutics in sports medicine market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global topical pain management therapeutics in sports medicine market are
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer, Inc.
    • Hisamitsu Pharmaceutical Co., Inc.
    • Mayne Pharma Group Limited
    • Sanofi (Chattem, Inc.)
    • GlaxoSmithKline plc
    • Endo Pharmaceuticals Inc.
    • Beiersdorf AG
    • Johnson & Johnson Services, Inc.
    • Topical BioMedics, Inc.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Topical Pain Management Therapeutics in Sports Medicine Market: Key Developments

Key players in the global topical pain management therapeutics in sports medicine market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global topical pain management therapeutics in sports medicine market. A few expansion strategies adopted by players operating in the global topical pain management therapeutics in sports medicine market are:

  • In September 2017, Sanofi India, a subsidiary of Sanofi, announced the launch of Combiflam ICYHOT, a new formulation of its blockbuster drug i.e. Combiflam. The oral blockbuster NSAID would now be offered in topical formulations including gels and sprays. This introduction is expected to enable the company to consolidate its position in the topical pain management sector in the near future
  • In November 2015, Dr. Reddy's Laboratories Ltd., a leading drug manufacturer in India, launched Nise D spray in the country. Nise tablet is a pre-existing and popular tablet formulation in India, which was introduced by Dr. Reddy in a spray form, owing to the rising adoption of the population for spray form of pain relievers.

The report on the global topical pain management therapeutics in sports medicine market discussed individual strategies, followed by company profiles of manufacturers of topical pain management therapeutics in sports medicine. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global topical pain management therapeutics in sports medicine market.

Topical Pain Management Therapeutics in Sports Medicine Market - Outline

There has been an increasing focus on development of new routes of drug administration to provide tailored treatments for patients, without decreasing efficacy of analgesia, in proportion to the progression of the knowledge of pain mechanisms. While acute pain acts as an alarm, chronic pain is a syndrome requiring meticulous selection of analgesic drugs of high bioavailability for long-term use. Such criteria are challenges that topical medications aim to overcome, allowing progressive delivery of active component, maintaining stable plasma levels, with a good safety profile. This review presents recent findings regarding topical formulations of the most widely used drugs for pain treatment, such as nonsteroidal anti-inflammatory agents, anesthetics, and capsaicin, and the role of physical agents as delivery enhancers (phonophoresis and iontophoresis). Although the number of topical agents is limited for use in peripheral conditions, increasing evidence supports the efficacy of these preparations in blocking nociceptive and neuropathic pain. Patient adherence to medical treatment is also a challenge, especially in chronic painful conditions. It is known that reduction of treatment complexity and pill burden are good strategies to increase patient compliance.

Evidence based on empirical practice has suggested that topically applied medications can be almost as effective as those taken orally, with a good safety profile in terms of adverse effects. The ultimate goal that motivates the development of topical preparations is the improvement of patient compliance to medical treatment, by providing efficient pain relief with less central nervous system effects and minimal drug regimen burden.

The medicine or drugs which are applied locally on the area which is being treated is called as topical drugs. ‘Topikos’ in Greek means ‘at a place’. Many creams and ointments which are applied to skin are often called a topical drugs. Topical pain management therapeutics are specialty products that are used to relieve acute musculoskeletal pain or general sprains or strains.

The therapeutics involve various drug classes such as analgesics, anesthetics, and skeletal muscle relaxants. Topical pain relievers are becoming increasingly popular in sports category owing to their site-specific action, cost-effectiveness, instant pain relief, and availability in the OTC segment

Global Topical Pain Management Therapeutics in Sports Medicine Market - Segmentation

Product

Gels

Creams

Sprays

Patches

  • Drug in Adhesives
  • Matrix
  • Reservoirs
  • Others

Therapeutic Class

Analgesics

  • Opioids
    • Fentanyl
    • Buprenorphine
    • Others
  • Non-opioids
    • Lidocaine
    • Diclofenac
    • Capsaicin
    • Methyl Salicylate
    • Others

Anesthetics

Skeletal Muscle Relaxants

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Topical Pain Management Therapeutics in Sports Medicine Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of topical pain management therapeutics in sports medicine market?

Topical pain management therapeutics in sports medicine market to reach US$ 3,470.3 Mn by 2027

What is the anticipated CAGR of the topical pain management therapeutics in sports medicine market in the forecast period?

Topical pain management therapeutics in sports medicine market is anticipated to expand at a CAGR of 8.8% from 2019 to 2027

What are the key driving factors for the growth of the topical pain management therapeutics in sports medicine market?

Topical pain management therapeutics in sports medicine market is driven by increase in incidence of musculoskeletal acute sports injuries

Which region is expected to project the highest market share in the global topical pain management therapeutics in sports medicine market?

North America accounted for major share of the global topical pain management therapeutics in sports medicine market

Who are the key players in the topical pain management therapeutics in sports medicine market?

Key players in the global topical pain management therapeutics in sports medicine market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Mayne Pharma Group Limited, Sanofi (Chattem, Inc.)

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Topical Pain Management Therapeutics in Sports Medicine Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Patch Design Technologies: Snapshot Regulatory Scenario, by Region/Globally

    5.2. WHO’s Pain Relief Ladder 

6. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Product, 2017–2027

        6.2.1. Gels

        6.2.2. Creams

        6.2.3. Patches

            6.2.3.1. Drug in Adhesives

            6.2.3.2. Matrix

            6.2.3.3. Reservoirs

            6.2.3.4. Others

    6.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product

7. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Therapeutic Class

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Therapeutic Class, 2017–2027

        7.2.1. Analgesics

            7.2.1.1. Opioids

                7.2.1.1.1. Fentanyl

                7.2.1.1.2. Buprenorphine

                7.2.1.1.3. Others

            7.2.1.2. Non-opioids

                7.2.1.2.1. Lidocaine

                7.2.1.2.2. Diclofenac

                7.2.1.2.3. Capsaicin 

                7.2.1.2.4. Methyl Salicylate 

                7.2.1.2.5. Others

        7.2.2. Anesthetics

        7.2.3. Skeletal Muscle Relaxants

    7.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class

8. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Region

9. North America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

        9.2.1. Gels

        9.2.2. Creams

        9.2.3. Patches

            9.2.3.1. Drug in Adhesives

            9.2.3.2. Matrix

            9.2.3.3. Reservoirs

            9.2.3.4. Others

    9.3. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

        9.3.1. Analgesics

            9.3.1.1. Opioids

                9.3.1.1.1. Fentanyl

                9.3.1.1.2. Buprenorphine

                9.3.1.1.3. Others

            9.3.1.2. Non-opioids

                9.3.1.2.1. Lidocaine

                9.3.1.2.2. Diclofenac

                9.3.1.2.3. Capsaicin 

                9.3.1.2.4. Methyl Salicylate 

                9.3.1.2.5. Others

        9.3.2. Anesthetics

        9.3.3. Skeletal Muscle Relaxants

    9.4. North America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

        9.5.1. By Product

        9.5.2. By Therapeutic Class

        9.5.3. By Country

10. Europe Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

        10.2.1. Gels

        10.2.2. Creams

        10.2.3. Patches

            10.2.3.1. Drug in Adhesives

            10.2.3.2. Matrix

            10.2.3.3. Reservoirs

            10.2.3.4. Others

    10.3. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

        10.3.1. Analgesics

            10.3.1.1. Opioids

                10.3.1.1.1. Fentanyl

                10.3.1.1.2. Buprenorphine

                10.3.1.1.3. Others

            10.3.1.2. Non-opioids

                10.3.1.2.1. Lidocaine

                10.3.1.2.2. Diclofenac

                10.3.1.2.3. Capsaicin 

                10.3.1.2.4. Methyl Salicylate 

                10.3.1.2.5. Others

        10.3.2. Anesthetics

        10.3.3. Skeletal Muscle Relaxants

    10.4. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe 

    10.5. Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

        10.5.1. By Product

        10.5.2. By Therapeutic Class

        10.5.3. By Country/Sub-region

11. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

        11.2.1. Gels

        11.2.2. Creams

        11.2.3. Patches

            11.2.3.1. Drug in Adhesives

            11.2.3.2. Matrix

            11.2.3.3. Reservoirs

            11.2.3.4. Others

    11.3. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

        11.3.1. Analgesics

            11.3.1.1. Opioids

                11.3.1.1.1. Fentanyl

                11.3.1.1.2. Buprenorphine

                11.3.1.1.3. Others

            11.3.1.2. Non-opioids

                11.3.1.2.1. Lidocaine

                11.3.1.2.2. Diclofenac

                11.3.1.2.3. Capsaicin 

                11.3.1.2.4. Methyl Salicylate 

                11.3.1.2.5. Others

        11.3.2. Anesthetics

        11.3.3. Skeletal Muscle Relaxants

    11.4. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific 

    11.5. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

        11.5.1. By Product

        11.5.2. By Therapeutic Class

        11.5.3. By Country/Sub-region

12. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

        12.2.1. Gels

        12.2.2. Creams

        12.2.3. Patches

            12.2.3.1. Drug in Adhesives

            12.2.3.2. Matrix

            12.2.3.3. Reservoirs

            12.2.3.4. Others

    12.3. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

        12.3.1. Analgesics

            12.3.1.1. Opioids

                12.3.1.1.1. Fentanyl

                12.3.1.1.2. Buprenorphine

                12.3.1.1.3. Others

            12.3.1.2. Non-opioids

                12.3.1.2.1. Lidocaine

                12.3.1.2.2. Diclofenac

                12.3.1.2.3. Capsaicin 

                12.3.1.2.4. Methyl Salicylate 

                12.3.1.2.5. Others

        12.3.2. Anesthetics

        12.3.3. Skeletal Muscle Relaxants

    12.4. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America Latin America 

    12.5. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

        12.5.1. By Product

        12.5.2. By Therapeutic Class

        12.5.3. By Country/Sub-region

13. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

    13.3. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Product, 2017–2027

        13.3.1. Gels

        13.3.2. Creams

        13.3.3. Patches

            13.3.3.1. Drug in Adhesives

            13.3.3.2. Matrix

            13.3.3.3. Reservoirs

            13.3.3.4. Others

    13.4. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

        13.4.1. Analgesics

            13.4.1.1. Opioids

                13.4.1.1.1. Fentanyl

                13.4.1.1.2. Buprenorphine

                13.4.1.1.3. Others

            13.4.1.2. Non-opioids

                13.4.1.2.1. Lidocaine

                13.4.1.2.2. Diclofenac

                13.4.1.2.3. Capsaicin 

                13.4.1.2.4. Methyl Salicylate 

                13.4.1.2.5. Others

        13.4.2. Anesthetics

        13.4.3. Skeletal Muscle Relaxants

    13.5. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa 

    13.6. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 

        13.6.1. By Product

        13.6.2. By Therapeutic Class

        13.6.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by Tier and Size of companies)

    14.2. Market Share / Position Analysis, by Company, 2018

    14.3. Company Profiles

        14.3.1. Teva Pharmaceutical Industries Ltd.

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Overview

            14.3.1.3. Strategic Overview

            14.3.1.4. SWOT Analysis

        14.3.2. Pfizer, Inc.  

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Financial Overview

            14.3.2.3. Strategic Overview

            14.3.2.4. SWOT Analysis

        14.3.3. Hisamitsu Pharmaceutical Co., Inc.  

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Overview

            14.3.3.3. Strategic Overview

            14.3.3.4. SWOT Analysis

        14.3.4. Mayne Pharma Group Limited

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Financial Overview

            14.3.4.3. Strategic Overview

            14.3.4.4. SWOT Analysis

        14.3.5. Chattem, Inc.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Financial Overview

            14.3.5.3. Strategic Overview

            14.3.5.4. SWOT Analysis

        14.3.6. GlaxoSmithKline plc.

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Financial Overview

            14.3.6.3. Strategic Overview

            14.3.6.4. SWOT Analysis

        14.3.7. Endo Pharmaceuticals Inc.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Financial Overview

            14.3.7.3. Strategic Overview

            14.3.7.4. SWOT Analysis

        14.3.8. Beiersdorf AG

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Financial Overview

            14.3.8.3. Strategic Overview

            14.3.8.4. SWOT Analysis

        14.3.9. Janssen Global Services, LLC 

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Financial Overview

            14.3.9.3. SWOT Analysis

        14.3.10. Topical BioMedics, Inc.

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Strategic Overview

            14.3.10.3. SWOT Analysis

List of Tables

Table 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

Table 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

Table 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

Table 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

Table 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Region, 2017–2027

Table 08: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

Table 10: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

Table 11: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 12: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

Table 13: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

Table 14: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

Table 15: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

Table 16: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

Table 17: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

Table 18: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 19: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

Table 20: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

Table 21: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

Table 22: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

Table 23: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

Table 24: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

Table 25: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 26: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

Table 27: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

Table 28: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

Table 29: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

Table 30: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

Table 31: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

Table 32: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 33: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

Table 34: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

Table 35: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

Table 36: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

Table 37: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

Table 38: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2017–2027

Table 39: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 40: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2017–2027

Table 41: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2017–2027

Table 42: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2017–2027

List of Figures

Figure 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn), CAGR and Share (%), by Geography, 2018 and 2027

Figure 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn) Forecast, 2017–2027

Figure 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018

Figure 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018

Figure 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Region, 2018

Figure 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

Figure 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gels, 2017–2027

Figure 08: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Creams, 2017–2027

Figure 09: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Sprays, 2017–2027

Figure 10: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Patches, 2017–2027

Figure 11: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017–2027

Figure 12: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class , 2018 and 2027

Figure 13: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Analgesics, 2017–2027

Figure 14: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anesthetics, 2017–2027

Figure 15: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Skeletal Muscle Relaxants, 2017–2027

Figure 16: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017–2027

Figure 17: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Region, 2018 and 2027 

Figure 18: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Region, 2017–2027

Figure 19: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 20: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027

Figure 21: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

Figure 22: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

Figure 23: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

Figure 24: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

Figure 25: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

Figure 26: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 27: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027 

Figure 28: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

Figure 29: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

Figure 30: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

Figure 31: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

Figure 32: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

Figure 33: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 34: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027 

Figure 35: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

Figure 36: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

Figure 37: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

Figure 38: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

Figure 39: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

Figure 40: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 41: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027 

Figure 42: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

Figure 43: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

Figure 44: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

Figure 45: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

Figure 46: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

Figure 47: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 48: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2018 and 2027 

Figure 49: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017–2027

Figure 50: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2018 and 2027

Figure 51: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2018 and 2027

Figure 52: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2018 and 2027

Figure 53: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017–2027

Figure 54: Global Topical Pain Management Therapeutics in Sports Medicine Market Share (%) & Market Share Range (%), by Company, 2016 

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

147

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved